BRCA1 and breast carcinoma: One percent of breast cancer present with sporadic mutations in BRCA1 with the promoter region in the gene being hyper-methylated in 11%–14% of cases thus inactivating the gene (Rigakos and Razis, 2012; Leidy et al., 2014).